Risk factors deteriorating severe exocrine pancreatic insufficiency measured by stool elastase after pancreatoduodenectomy and the risk factors for weight loss

다국어 초록 (Multilingual Abstract)

Purpose: The measurement of stool elastase (SE) level is useful for evaluating pancreatic exocrine function. This study aimed to determine the risk factors for severe exocrine pancreatic insufficiency (EPI) after pancreatoduodenectomy (PD), and analyze serial changes in nutritional markers and weight based on the SE level.
Methods: Among patients who underwent PD for periampullary disease, patients whose preoperative and postoperative SE levels were measured were included in the study. The deteriorated (exocrine function) group comprised patients whose SE levels decreased from ≥100 μg/g preoperatively to <100 μg/g postoperatively. Patients whose weight 12 months postoperatively was greater than that 3 months postoperatively were classified into the weight-recovery group.
Results: Of the 202 included patients, the deteriorated group had a higher incidence of preoperative SE level above 200 μg/g, benign pathology, and the presence of a clinically relevant postoperative pancreatic fistula than the maintained group. Patients who did not undergo weight recovery had a higher rate of history of adjuvant radiotherapy compared to the no-recovery group.
Conclusion: The evaluation of EPI by measuring SE alone is not sufficient because it does not reflect the nutritional status of patients, and a comprehensive approach that considers other parameters is required for EPI management.

목차 (Table of Contents)

• INTRODUCTION
• METHODS
• RESULTS
• DISCUSSION
• REFERENCES

참고문헌 (Reference)

1 Van de Vijver E, "Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT" 53 : 61-64, 2011

2 Clavien PA, "The Clavien-Dindo classification of surgical complications : five-year experience" 250 : 187-196, 2009

3 Sziegoleit A, "Studies on the sterol-binding capacit y of human pancreatic elastase 1" 100 : 768-774, 1991

4 Okano K, "Remnant pancreatic parenchymal volume predicts postoperative pancreatic exocrine insufficiency after pancreatectomy" 159 : 885-892, 2016

5 Seiler CM, "Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension" 37 : 691-702, 2013

6 Neophytou H, "Predictive factors of endocrine and exocrine insufficiency after resection of a benign tumour of the pancreas" 79 : 53-61, 2018

7 Tran TC, "Pancreatic fibrosis correlates with exocrine pancreatic insufficiency after pancreatoduodenectomy" 25 : 311-318, 2008

8 Hollemans RA, "Pancreatic exocrine insufficiency following acute pancreatitis : systematic review and study level meta-analysis" 18 : 253-262, 2018

9 Goess R, "Pancreatic exocrine insufficiency after pancreatic surgery" 58 : 151-159, 2016

10 Nordback I, "Obstructed pancreaticojejunostomy partly explains exocrine insufficiency after pancreatic head resection" 42 : 263-270, 2007

11 Bruno MJ, "Maldigestion associated with exocrine pancreatic insufficiency : implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment" 90 : 1383-1393, 1995

12 Bruno MJ, "Maldigestion and exocrine pancreatic insufficiency after pancreatic resection for malignant disease : pathophysiology and treatment" 1 : 55-61, 2001

13 Kim E, "Influence of preoperative nutritional status on clinical outcomes after pancreatoduodenectomy" 20 : 1051-1061, 2018

14 de la Iglesia-Garcia D, "Increased risk of mortality associated with pancreatic exocrine insufficiency in patients with chronic pancreatitis" 52 : e63-e72, 2018

15 Beharry S, "How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease?" 141 : 84-90, 2002

16 Tran TC, "Functional changes after pancreatoduodenectomy : diagnosis and treatment" 9 : 729-737, 2009

17 Löser C, "Faecal elastase 1 : a novel, highly sensitive, and specific tubeless pancreatic function test" 39 : 580-586, 1996

18 Capurso G, "Exocrine pancreatic insufficiency : prevalence, diagnosis, and management" 12 : 129-139, 2019

19 Erickson JA, "Evaluation of a fecal pancreatic elastase-1 enzyme-linked immunosorbent assay : assessment versus an established assay and implication in classifying pancreatic function" 397 : 87-91, 2008

20 Lévy P, "Estimation of the prevalence and incidence of chronic pancreatitis and its complications" 30 : 838-844, 2006

21 Kim H, "Effects of pancreatic enzyme replacement therapy on body weight and nutritional assessments after pancreatoduodenectomy in a randomized trial" 18 : 926-934, 2020

22 Park JW, "Effects of pancreatectomy on nutritional state, pancreatic function and quality of life" 100 : 1064-1070, 2013

23 Ito K, "Duodenum preser vation in pancreatic head resection to maintain pancreatic exocrine function(determined by pancreatic function diagnostant test and cholecystokinin secretion)" 12 : 123-128, 2005

24 Tanaka T, "Clinical and experimental study of pancreatic exocrine function after pancreaticoduodenectomy for periampullary carcinoma" 166 : 200-205, 1988